ProShares Ultra Nasdaq Biotechnology Fund (BIB): Your Chance to Get in Early on Massive Opportunities in Biotech

As True Wealth Systems editor Steve Sjuggerud has said many times over the years, "If you catch just one biotech bull market in your lifetime, you may never have to work again..."

 

And the returns in the ProShares Ultra Nasdaq Biotechnology Fund (BIB) – a double-long exchange-traded fund – supports Steve's statement. (Remember, the returns for BIB will be higher than a simple biotech index due to leverage. But the returns for the normal index are still incredible.)

 

BIB hit a low of $8.48 per share on August 8, 2011. It has soared to more than $160 today – a return of nearly 20 times in less than four years. (more)

Please share this article